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PRRS is one of the most challenging diseases for world-wide pig production. Attempts for a sustainable control of
this scourge by vaccination have not yet fully satisfied. With an increasing knowledge and methodology in disease
resistance, a new world-wide endeavour has been started to support the combat of animal diseases, based on the
existence of valuable gene variants with regard to any host-pathogen interaction. Several groups have produced a
wealth of evidence for natural variability in resistance/susceptibility to PRRS in our commercial breeding lines.
However, up to now, exploiting existing variation has failed because of the difficulty to detect the carriers of
favourable and unfavourable alleles, especially with regard to such complex polygenic traits like resistance to PRRS.
New hope comes from new genomic tools like next generation sequencing which have become extremely fast
and low priced. Thus, research is booming world-wide and the jigsaw puzzle is filling up – slowly but steadily. On
the other hand, knowledge from virological and biomedical basic research has opened the way for an “intervening
way”, i.e. the modification of identified key genes that occupy key positions in PRRS pathogenesis, like CD163.
CD163 was identified as the striking receptor in PRRSV entry and its knockout from the genome by gene editing
has led to the production of pigs that were completely resistant to PRRSV – a milestone in modern pig breeding.
However, at this early step, concerns remain about the acceptance of societies for gene edited products and
regulation still awaits upgrading to the new technology. Further questions arise with regard to upcoming patents
from an ethical and legal point of view. Eventually, the importance of CD163 for homeostasis, defence and
immunity demands for more insight before its complete or partial silencing can be answered. Whatever path will
be followed, even a partial abolishment of PRRSV replication will lead to a significant improvement of the disastrous
herd situation, with a significant impact on welfare, performance, antimicrobial consumption and consumer
protection. Genetics will be part of a future solution.
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Background
The production of PRRS resistant pigs by gene editing
has produced a milestone in pig breeding and a big hope
for a sustainable combat of an important disease. How-
ever, much remains to be done to reach the demands of
practical breeding. While gene editing methods try to
modify genes that play important roles in the pathogen-
esis of a disease, functional genome analysis and associ-
ation studies intend to detect and exploit naturally
existing genetic variation in such genes. Both approaches
are in process at a world-wide endeaver to improve re-
sistance of pigs to infectious diseases. The aim of this
review is to provide insight into status and potential of
these applications with regrd to PRRS, with a glimpse on
future and existing concerns. Conclusions are based on
the existing literature.
Genetic resistance as a first choice of prophylaxis
Breeding for disease-resistant pigs might be the ultima
ratio in combatting infectious diseases. Regardless of
whether pigs would be resistant sensu stricto, (i.e., the ab-
solute prevention of an infection, or just tolerating the in-
fection) minimal amplification and shedding of the
pathogen and minimal effects on health and performance
could be achieved. Thus, the infectious pressure in and
between herds could be efficiently reduced, followed by
diminished disease incidence, improved performance and
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product quality, reduced antibiotic treatment, improved
consumer protection and increased animal welfare [90].
Genetic resistance in practical breeding
Disease-resistant breeds, populations or animals are of
considerable importance to livestock. Prime examples
are resistance to coccidiosis and Marek’s disease in fowl
(e.g. [20]), to trypanosomiasis [77] and ticks [81] in cat-
tle at tropical sites, to mastitis in dairy cattle (e.g. [41]),
and to gastro-intestinal nematodes in sheep [109]. In
pigs, however, examples of genetic resistance in com-
mercial breeding programmes are sparse. Two examples
are resistance to fimbriated F18 [121] and F4 [49]
Escherichia coli. They represent rare cases of single-gene
controlled genetic resistance. F18 fimbriated E.coli cause
post-weaning diarrhoea and oedema disease [73] and re-
sistance is realised by a receptor variant that does not
bind any type of E.coli F18 fimbriae. Similarly, the right
F4 receptor variant gives resistance to neonatal diar-
rhoea caused by most of F4-fimbriated E.coli. Other ex-
amples include the breeding for improved immune
responsiveness, i.e. a higher general reactivity in humoral
and cellular immunity in pigs (e.g. [129]). In spite of the
currently limited commercial applications in swine, a wide
range of genetic variation has been observed in genetic re-
sistance to different bacterial, viral and parasitic diseases.
A comprehensive search for disease resistance might
identify differences in susceptibility/resistance in any host-
species with regard to any relevant pathogen [90]. How-
ever, most of this genetic variation cannot be used in
practical breeding, because of the difficulty in recognising
favourable and unfavourable gene variants within the
breeders. Their identification is impeded by highly variable
and influential farm-specific environmental effects (e.g.,
pathogen load, immunity, housing, feeding and manage-
ment conditions), the polygenic inheritance mode of most
resistance traits, the limited availability of animal models
and limited detailed knowledge of pathogenesis for most
porcine diseases.
Improving genetic disease resistance
While classical breeding is, thus generally inappropriate
for efficient improvement of genetic resistance, evolved
knowledge of the porcine genome combined with new
tools and technologies – developed in the context of
genome projects – have created new opportunities to
dissect the genetic control of complex traits, including
host responses to infection [4]. Alternatively to classical
breeding, responsible gene variants can be identified via
experiments in selected populations that vary signifi-
cantly in resistance/susceptibility, under standardised
environmental conditions, including time point of chal-
lenge and quantity of the pathogen. Once the respon-
sible gene variants are identified, causal variants in
experimental populations need to be validated in com-
mercial farms to confirm segregation and association,
prior to application in selection. Then, breeders can be
selected via marker-assisted and genomic selection [74].
Provided there is societal consent, desirable gene vari-
ants can even be introduced into breeding populations
via genetic engineering (e.g., [84]). In addition, under-
standing the molecular basis of genetic resistance will
help improving the knowledge of the underlying mecha-
nisms of disease and disease resistance, thus promoting
new and enhanced developments in diagnostics, therapy
and prophylaxis.
Examples on the way
We have seen there are limited examples of applicable
gene variants already in the field to improve genetic re-
sistance in swine [49, 121]. However, the search for signifi-
cant and applicable gene variants has developed into an
ever-expanding and successful branch of clinical research,
including viral (Pseudorabiesvirus [88]; Influenza A (e.g.
[143]); bacterial (Haemophilus parasuis [131]; Actinobacil-
lus pleuropneumoniae [93, 94]; Mycoplasma hyopneumo-
niae (e.g., [108]); Streptococcus suis [136]) and parasitic
diseases (Sarcocystis [89]; Ascaris suum [100, 101]). More
than 2,500 quantitative trait loci (QTL) have been pub-
lished for health parameters in the pig, among them 400
for resistance/susceptibility against a broad range of patho-
gens (http://www.animalgenome.org/QTLdb/; current sta-
tus: October 2016). QTL are gene loci which participate
in the control of quantitative distributed traits such as
milk yield, growth performance and disease resistance.
The most remarkable results have been seen in resist-
ance to PRRSV.
Porcine Reproductive and Respiratory Syndrome
(PRRS)
PRRS is one of the most devastating diseases in swine,
worldwide (for overview see [147]). The disease causes
respiratory and reproduction failures. Losses for the US
pig industry were estimated at over $ 650 million annu-
ally, excluding costs for diagnosis, vaccination, treatment
and biosecurity [44]. PRRSV is a single stranded RNA
virus from the Arteriviridae family and it can be found
in two genotypes (US [type 2] and EU [type 1]). Each
genotype comprises of thousands of genetic and anti-
genic heterogenic strains [147]. PRRSV replicates in cells
of the monocyte/macrophage lineage, especially in acti-
vated macrophages. Its high variability and its ability for
immune evasion make it extremely difficult to design
sustainable vaccines, especially under heterologous situa-
tions (Wilkinson et al. [130]). Thus, other solutions are
searched for to combat the disease, among them the use
of genetic resistant pigs.
Reiner Porcine Health Management  (2016) 2:27 Page 2 of 11
Natural genetic disease resistance against PRRS in
swine breeds and populations
Halbur et al. [38] provided initial indications of genetic
differences in susceptibility/resistance of pigs against
PRRS. Duroc pigs showed lower performance combined
with an increased severity of lung lesions and antibody
titres after infection with PRRSV than Meishan pigs.
Clinical abortion rates were found to be associated with
IFNγ and influenced by sows’ genetics [67]. A genetic
background for differences in performance, severity of
lesions, viral titres, infected macrophages and immuno-
logical parameters has also been described by Petry et al.
[85], Vincent et al. [119, 120], Doeschl-Wilson et al. [26]
and Reiner et al. [91], although differences were often
small and partially inconsistent over time. Lean lines
(Duroc and Hampshire) have been found to be more
susceptible than lines selected for higher reproductivity.
Ait-Ali et al. [1] reported on favourable macrophages in
Landrace pigs and assumed the density and distribution
of CD169 and IL-8 levels to be critical factors. High
levels of IL-8 and low levels of IFNγ were also associated
with PRRSV resistance by Petry et al. [86].
PRRS resistance: tracking down the molecular
basis by genome-wide genetic association and
differential expression studies
These results provided enough evidence for a genetic
background of PRRS resistance and remarkable differ-
ences in susceptibility between breeds or at least pop-
ulations. For the next step, pigs differing at most in
susceptibility/resistance were used in experiments to take a
detailed look at their genetic peculiarities. Three major
setups were applied initially: QTL analysis [39] and
genome-wide association study (GWAS) were used to
identify chromosomal areas and eventually single nucleo-
tide polymorphisms (SNPs) associated with PRRS pheno-
types (e.g., degree of viremia, lung lesions and performance
after PRRSV infection [13–15], antibody response [105])
and differential expression experiments to detect
genes via differences in their expression levels in sus-
ceptible and resistant pigs [103, 104]. The most sig-
nificant results have been achieved by Joan Lunney
(USDA), Bob Rowland (Kansas State University) and col-
leagues, particularly in the context of the PRRS Host
Genetics Consortium (PHGC, for a review, see [69]).
Based on up to 60,000 SNP markers together with
new statistical tools, more than 30 QTL for resistance
against PRRS have been mapped to 11 chromosomes
http://www.animalgenome.org/QTLdb/ [13, 15]. As part
of the PRRS Host Genetics Consortium, a genome-wide
association study based on 190 pigs from a commercial
breeding line and the Illumina PorcineSNP60 BeadChip
detected associations with viral load and body weight
after PRRSV infection. A major QTL region was mapped
to chromosome 4 (SSC4), explaining 16 % of genetic
variance for virus load with a frequency for the
favourable allele of 0.16 and a heritability of 0.30 [13].
One of the most limiting factors in association studies
has been the density of gene markers. Next generation
sequencing is a recent technological breakthrough that
is speeding up the genetics and genomics of a broad
range of traits, conferring new opportunities for high-
throughput low cost genotyping. Costs for sequencing
have dropped by 1:100,000 during the last 15 years.
Marker density can be increased by 104 to 105 as com-
pared to conventional SNP-chips which has led to the
concept of genotyping by sequencing (for overview see
[51]). Such technics may help to raise our understanding
of host-PRRSV interaction to a higher end much more
complex level, including the complete genomic informa-
tion of both the host and the virus. Next generation se-
quencing will have a high impact on the understanding
of the virus’ adaption to replication in the host [18, 68].
GBP5 is an important candidate gene for PRRS resistance
The highest linkage disequilibrium was found for SNP
WUR10000125. The interferon-induced guanylate-binding
protein 5 gene (GBP5) was identified as the most likely
candidate in a total of eight consecutive and independent
trials [13–15]. This gene was differentially expressed and
validated in different pig populations [53] and an intronic
SNP (rs340943904) (close to WUR10000125, but not on
the 60 k SNP chip) was found to be responsible for intro-
ducing a splicing site that truncated the C-terminal 88
amino acids in the recessive A-allele. GBP5 is involved in
immune response to bacterial and viral infection in differ-
ent species, namely in the inflammatory response and the
assembly of the inflammasome in mammals [107], which
strongly depends on the C-terminal 67 amino acids which
are highly conserved between species [12]. Although the
exact role of GBP5 in PRRSV defence remains to be iden-
tified, this SNP is the putative quantitative trait nucleotide
(QTN) (i.e., the SNP most likely to be responsible for the
QTL on SSC4). In addition, Boddicker et al. [14] only
found small effects for resistance to PRRS on SSC1, 5, 7
and X. Further research is needed to show the generality
of these findings in other global pig breeds.
A second approach to detect underlying molecular dif-
ferences in PRRS susceptibility/resistance was performed
via microarray-based gene expression analysis, in vivo
[2, 6, 9, 11, 36, 42, 46, 75, 103, 104, 137–141, 146] or
in vitro [98, 99]. Several immune response pathways
were upregulated after infection and several hundreds
of differentially expressed genes were detected, but
this did not lead to a simple identification of directly
responsible genes. One major concern with differen-
tial expression (DE) studies is that many differentially
expressed genes (A) do not necessarily need to carry
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the responsible mutation. Instead, their differential expres-
sion is achieved via the products of other genes (B) that
regulate gene expression by binding to the promoter, the
5′ and 3′ untranslated region or to other regulatory
elements of the A genes. These B genes, however, do not
necessarily need to be differentially expressed, provided
the relevant mutation leads to an amino acid exchange,
resulting in altered efficiency of the gene products of
genes B at the promoters of genes A. Thus, they may not
be detected in DE studies. Thus, the strength of DE stud-
ies lies mainly in the detection of the gene networks and
pathways involved and in integrating the analysis of gen-
etic and DE data.
The role of genetic variation in type I interferon
genes
Type I interferons are a heterogeneous group of cytokines,
important in antiviral response. Genetic variation has been
linked to susceptibility to viral diseases, and PRRSV has
been found to suppress type I IFN production as a major
strategy for evading the immune system [60, 80, 82]. Sang
et al. [97] discovered more than 100 polymorphisms in 39
functional genes from the type I interferon family. More
than 20 polymorphic mutants have been linked with dif-
fering anti-PRRSV activities in vitro [97].
Genetic variation in autochtonous breeds may
contribute genetic resistance against PRRS
Rare breeds, often autochthonous to some regions or
countries and poorly adapted to modern pig production,
are a valuable source of rare gene variants with some-
times unexpected effects. Rare or even lost SNPs might
be (re-)introduced via gene editing methods or by gen-
etic introgression. However, this requires knowledge of
these effects and, therefore, the breeds carrying the rare
SNPs. One potential example was provided by Li et al.
[62] who identified an Mx1 (myxovirus resistance pro-
tein 1) promoter variation, potentially associated with
PRRS resistance. Mx1 exhibits potent anti-RNA viral ac-
tivity [7, 78] and is involved in early host defence against
PRRSV [19, 145]. A second candidate gene, potentially
involved in PRRSV resistance, with the valuable allele
preferentially restricted to Chinese autochthone breeds,
is the ubiquitin-specific protease 18 (USP18; [63]).
The role of microRNA genes
MicroRNAs are small non-coding RNA, involved in
post-transcriptional gene regulation [92]. They modify
mRNA stability by interaction with its 3′ untranslated re-
gion and have been shown to be involved in viral patho-
genesis in pigs, e.g. swine influenza virus and pseudorabies
virus (He et al. [40]; Anselmo et al. [5]; Loveday et al.
[66]). Up to now, no microRNA variability has been de-
scribed in association with PRRS resistance/susceptibility.
However, the porcine microRNAome has been studied
in PRRSV-infection and the expression of several
microRNAs is altered by PRRSV infection [42, 47, 64].
These results could lead to microRNA-based anti-PRRSV
therapies in the future.
Support from basic virus research: the PRRSV
receptors
Most genes and molecules involved in PRRS pathogen-
esis escape detection via genetic and genomic methods,
if they are not variable in sequence or expression, or if
this variability is not present in the studied populations.
Thus, basic virus research is of high importance in the
attempt to resolve the pathogenesis of PRRS and to de-
tect candidate genes for PRRS-resistance.
At least six cellular molecules have been described so
far as putative receptors for PRRSV, including CD163,
the cysteine-rich scavenger receptor (SRCR; [17]), sia-
loadhesin (CD169; siglec-1; [29]), CD151 [106], heparin
sulfate [50], vimentin [52] and CD209 [45], reviewed by
Zhang and Yoo [144].
CD163
CD163 is restrictively expressed in cells from the mono-
cyte/macrophage lineage, and significant expression is
exclusively found in activated (major) tissue macro-
phages, together with complement and Fc receptors,
other scavenger receptors, and receptors for mediators,
adhesion molecules and growth factors [3, 112]. Macro-
phages not or only newly involved in inflammation and
defence do not express CD163 to any substantial degree
[8, 118]. Activation of TLRs (e.g., TLR4) by LPS or other
pathogen-associated molecular patterns (PAMPs) in-
creases IL10 [125], one of the strongest upregulators of
CD163 in humans [133]. A second important activator
of CD163 is stress (glucocorticoids) [43, 112].
One major function of CD163 is in the receptor-
mediated endocytosis that delivers extracellular substrates
to the endo- and lysosomes of scavenger cells for intracel-
lular metabolism and activation of ligand-specific signal
pathways that direct the right answer to the respective
substrate [113]. While ligands are delivered to early endo-
somes, CD163 recycles to the plasma membrane for new
rounds of endocytosis [102]. These events are best recog-
nized regarding the elimination of toxic cell-free haemo-
globin from the serum as an important physiological
metabolic pathway [56, 102]. Another role of the scaven-
ger receptor seems to be the receptor-mediated internal-
isation of pathogens, and coincidentally its role as an
innate immune sensor for Gram-positive and Gram-
negative bacteria, linking bacterial infection with inflam-
mation (e.g., via pro-inflammatory cytokines like TNFα
[116]). However, some pathogens have developed mecha-
nisms to evade these physiological processes and use the
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receptor to enter their host cells, namely African swine
fever virus (ASFV; [96]) and PRRSV [17, 83, 114].
CD163 and PRRSV
CD163 has been well documented as attachment and in-
ternalization receptor in ASFV [96], the PRRSV-related
Simian Haemorrhagic Fever Virus (SHFV; [16]) and
PRRSV [17]. PRRSV was first identified to enter the cell
via a common receptor-dependent endocytosis [55], rely-
ing on the clathrin-mediated pathway and a low pH and
shifting the virus from the cell surface to early endosomes
[79]. The receptor was found to be responsible for the
highly specific tropism of the virus [54]. Since then, sev-
eral attachment factors have been studied extensively as
potential PRRSV receptors and CD163 and CD169 were
identified the most likely candidates involved. However,
only CD163 has been shown capable of conferring PRRSV
permissiveness to cell lines unsusceptible to PRRSV, even
in the absence of CD169 (e.g., [17, 83, 113, 114, 116, 123,
124]). It was shown that PRRSV permissivity was con-
ferred by CD163 independent of the PRRSV genotype in-
volved (1 [EU] or 2 [US]) [17, 61]. Down-regulation of
CD163 (but not CD169) in susceptible cells by ADAM17
was able to completely block PRRSV infection [37]. All
these data show that CD163 alone can transfer PRRSV
permissiveness to non-responsive cells and establish a
productive replication cycle [144]. The role of CD163 was
finally proven in the gene editing experiments of Prather
et al. [87] and Whitworth et al. [128], who transferred
PRRSV resistance to pigs by deleting CD163 sequences
from the pigs’ genome. However, they had no success
when deleting CD169.
The central role of CD163 in PRRSV replication has
never been in debate. There was just some discussion
about the step where the binding between CD163 and
PRRSV would take place. Van Gorp et al. [113–116] pro-
vided evidence for first interactions between PRRSV and
CD163 during virus uncoding in early endosomes. How-
ever, the lack of measureable amounts of CD163 in con-
tact with PRRSV on the cell surface might be due to a
fast cycling process of CD163 between cell surface and
endosomes as described by Schaer et al. [102] and Zhang
and Yoo [144]. Minor differences between experiments
in terms of efficiency of PRRSV replication seem to be
more a matter of receptor interaction and membrane
lipid environment than of differences between PRRSV
genotype, although variability of the pathogen itself also
affects the quantitative outcome of PRRSV replication.
The fact that not all cells that express CD163 can be
infected by PRRSV which is important for realisation of
PRRSV-specific cell tropism [144] and that PRRSV
shows a restricted tropism for subsets of porcine macro-
phages in vivo might be a question of CD163 quantity or
of interaction with other, maybe until now not identified
co-receptors [34]. The expression of CD163 on macro-
phages in different microenvironments in vivo, may deter-
mine the replication efficiency and subsequent virulence
of PRRSV [83].
CD163 domains
CD163 consists of nine cysteine-rich tandem repeats,
forming the extracellular scavenger receptor, a trans-
membrane domain and the intracellular cytoplasmic tail.
Different from the situation with haemoglobin (domains
2 and 3; [30]), the essential parts of CD163 in PRRSV
entry seems to be related to domain 5, the two proline-
serine-threonine (PST)-rich regions and a few others,
but not with the complete receptor [113]. The first 4 N-
terminal domains and the C-terminal 223 residues (cyto-
plasmic tail) [59] are not relevant for PRRSV-replication.
The transmembrane domain is essential, but not specific
[127]. The interacting PRRSV glycoproteins responsible
for receptor binding and infection are GP2a, GP3, GP4
and E, [110]. GP4 and GP2a are especially important
[21]. Replacing ORFs 2a to 4 with EAV ORFs keeps the
virus viable and infectious, but protects macrophages
from infection [110].
Glycosylation of GP2a and GP4 by glycans can have
different effects on PRRSV replication, depending on the
PRRSV genotype [22, 126, 134]. However, transitions are
fluent, because of the role of lipids and cholesterol from
the lipid rafts of the outer plasma membrane that inter-
act with embedded proteins and receptors [28, 142]. As
a putative ion channel protein, the E protein is involved
in decreasing pH values as a further part of a successful
uncoating process [58].
Supporting receptors
Sialoadhesin (CD169) is a transmembrane glycoprotein, a
lectin, restricted to activated tissue macrophages [76, 132]
and involved in cell-cell interaction. Expression can be
induced in macrophages by IFNα and IFNγ during the in-
flammatory process [95]. The receptor facilitates pathogen
interactions and uptake of sialylated pathogens (e.g., HIV
[95] and PRRSV [25, 29, 117]. Especially the amino
acids S107 and R116 bind sialic acid of PRRSV GP5
[25, 48, 111]. Sialoadhesin seems to facilitate attach-
ment of PRRSV, eventually together with heparin sul-
fate, and internalisation, but not replication of the
virus [24, 114, 116]. A gene editing experiment that de-
leted CD169 found full PRRSV-permissive macrophages
and unaltered viremia and antibody production in the
pigs [87]. The authors conclude that sialoadhesin is
not required for PRRSV infection and that the ab-
sence of the CD169 gene neither prevents PRRS nor
alters PRRS pathogenesis.
Heparin sulfate is widely distributed on the surface
of most mammalian cells. Heparin sulfate, heparin-like
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proteins and proteoglycans bind to GP5/M heterodimers
and the M complex of PRRSV in a virus-dependent man-
ner [23, 50]. Together with sialoadhesin, heparin sulfate
seems to propagate the interaction between PRRSV and
its specific receptor(s), but heparin sulfate is not necessar-
ily required for PRRSV entry [23].
CD151 is involved in numerous cell functions and cell
signalling [32]. Silencing the gene made susceptible cells
resistant, while overexpression made resistant cells sus-
ceptible to PRRSV, making CD151 a key receptor for
PRRSV infection [106]. Blocking CD151 by microRNA
(miR506) prevents the cells from being infected [135].
However, CD151 is restricted to the erythroid cell
lineage and is not expressed on macrophages.
Vimentin and CD209 are further putative receptors
that might be involved in varying efficiency of PRRSV
binding and replication [45, 52].
A gene editing breakthrough in PRRS resistance?
All these results regarding PRRSV receptors finally led
to gene editing experiments and the knockout of
PRRSV-receptor function in CD169 [87] and CD163
[128] in gene-edited pigs. Loss of CD169 did not affect
PRRSV replication, but gene-edited pigs without CD163-
receptor function were protected from PRRSV. The pigs
showed no fever, respiratory or other clinical signs, and
no lung pathology, viremia or antibody response after in-
oculation with a NVSL 97–7895 PRRSV isolate in a con-
trolled study. In addition, no problems occurred during
pregnancy and growth of the piglets until challenged
with the PRRSV isolate at the age of 3 weeks.
What is gene editing?
The goal of improving livestock genomes by direct ma-
nipulation is old. Its development was accompanied by
serious problems in terms of site-specificity (precision),
efficiency of the methods used and a lack of acceptance
in wider society. Thus, unlike transgenic crops, no trans-
genic livestock has ever gained commercial approval
[57]. All these problems may have been overcome with
the introduction of gene editing via CRISPR/CAS9 [27].
The system combines an endonuclease with a specific
short guiding (sg) RNA sequence. Like a primer in PCR,
this sequence provides accurate specificity, while the
linked enzyme can cleave and modify the DNA at
exactly the position targeted by the sgRNA sequence.
The key-step of this method is the double strand break
in DNA and the interaction with cellular DNA repair
mechanisms that leads to a high degree of failures
(50 %) when joining the ends or even higher, when hom-
ology directed repair is induced by the introduction of
the desired new sequence [27]. The system can also be
used in a multiplex manner to edit different genes in
one step. However, comparable to the amplification of
incorrect sequences by primer mismatching in PCR, care
must be taken not to introduce unintended mutations
anywhere in the genome at off-target sites. New
methods have been developed to minimise the off-target
size problem [71]. Originally, the CRSISPR Cas9 system
was part of natural, sequence-specific immunity in bac-
teria, responsible for the introduction of DNA double-
strand breaks into invading plasmids and phages [35].
Taken together, concerns about the precision and efficiency
of transgenics have been overcome by this new method in
previously inconceivable way. The first genome editing ex-
periment in pigs succeeded to resilience the African Swine
Fever receptor by its warthog homologue [65].
Concerns about gene edition as a tool to
generate genetic resistance to combat PRRS
Gene editing and regulation by authorities
Gene editing can introduce mutations to the genome with-
out adding any footprints associated with the technology.
Thus, genome modifications cannot be distinguished from
natural mutations [57]. Further, vectors to introduce foreign
DNA into transgenic organisms, which might prove hazard-
ous to consumers, are no longer needed. Both factors have
led to the enthusiastic acceptance of gene editing by most
researchers, the scientific community and the industry. Un-
like transgenic organisms, gene-edited plants and animals
may not need regulatory oversight [70, 122], provided the
human germ line is not involved. Animals and products
might not even be classified as genetically modified organ-
isms (GMO). However, as the methodology explodes and a
vast number of gene-edited livestock will be produced in the
coming years, societal interpretation is currently difficult to
predict. However, restrictions are likely.
Patenting gene-edited PRRS resistance
A second concern is related to upcoming patents. Gener-
ally, societies have to decide whether naturally occurring
receptors or gene variants with a potential to improve
health and welfare should be reserved exclusively for cer-
tain companies. The future always brings changes and the
ability of populations and species to change is based on
their genetic variability. As any individual can carry a max-
imum of two alleles at any position in the genome, re-
source populations often lose rare alleles with decreasing
population size. These alleles, once lost, cannot be reintro-
duced by gene editing, as their favourable effects have
never been documented. A single breed is not enough to
fulfil the different demands of diversified markets world-
wide. A chance to become resistant to PRRS needs to be
retained for other breeds, lines and populations too.
Side-effects of CD163-edited knockout pigs
The facts outlined above for CD163 show that this pro-
tein has not evolved solely as a PRRSV receptor, but
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with a broad spectrum of tasks, including the elimin-
ation of pathogens other than PRRSV and the regulation
of the immune system. CD163 awaits the discovery and
evaluation of further involvements and mechanisms.
Any knockout of CD163 as a whole or in part needs me-
ticulous investigation of impacted pigs under field condi-
tions, including the effects of other pathogens and
adverse conditions. Work is currently in progress and
results are expected in future.
Stability of the genetic resistance in the CD163 knockout pig
Will CD163 knockout protect against other and upcom-
ing PRRSV strains? One common concern surrounding
disease resistance is whether pathogens will be able to
adapt to host resistance like they acquire resistance to
antibiotics. Acquiring resistance is possible in theory,
but the method is unlikely to be similar, because there
are no plasmids harbouring information for an arbitrary
switch to new tropism. Some examples of single muta-
tions provoked tissue or even species shift under “nat-
ural” conditions, although species shifts are very rare
events in the evolution of most viruses [33]. A prime ex-
ample is the Influenza A virus (e.g. [72]). Other exam-
ples arise from the Coronaviridae (e.g., SARS [31]) and
TGE/PRCV [10] viruses.
The specific risk for the development of mutations
that could alter cell or even species tropism might be
high in PRRSV-infected pig herds. As a RNA virus,
PRRSV has high mutation rates and the herd situation
generally provides conditions that lead to the crowding
of different pathogens or strains. Forsberg et al. [33]
conclude that a supposed interspecies transmission for
PRRSV took place before 1981. However under the con-
ditions of current pig-PRRSV-interaction - including a
high degree of adaptation of the virus to its host, an un-
manageable multitude of strains and genotypes and
highest burdens within pigs and herds - mutations in the
PRRSV genome that might overcome CD163 could arise
within a much shorter period.
The tremendous all-or-nothing-principle of CD163 on
PRRSV replication could provide an unique and wide-
spread solution to the PRRS problem. However, because
only one receptor is involved, it runs a strong risk of being
overcome by one or few SNPs. Work by Frydas et al. [34]
indicates that tropism of PRRSV may change, at least
for type 1. The fact that some isolates infected signifi-
cantly more cells in nasal mucosa than others, sug-
gests the potential existence of additional receptors.
Up to now, the CD163-knockout experiment was only
conducted with type 2 isolates.
On the other hand, differences in oligo- or polygenic
pathways that are involved in the immune answer to
PRRSV infection are much more complex. This com-
plexity hinders their elucidation and the all-or-nothing-
principle of resistance. However, if such natural resistance
could be implemented, the odds that PRRSV would over-
come these genetic changes would decrease. It is impos-
sible to predict exactly what will happen. Some good
examples arise from indigenous (autochthone) breeds,
evolved under endemic disease challenge. Such breeds
have developed sustainable resistance that makes them su-
perior to others. This aspect further underlines the neces-
sity to preserve genetic and breed diversity in swine.
Conclusion
The detection and knockout of CD163 as the receptor re-
sponsible for PRRSV replication in pigs is a milestone in
modern pig production. Complete or even partial elimin-
ation of PRRSV replication would lead to a significant im-
provement in the disastrous situation in infected herds,
with significant impact on welfare, production effi-
ciency, performance and consumer protection. How-
ever, the complete function of the receptor and its
reasonable modification still requires elucidation, and the
evaluation of other gene variants involved in immuno-
logical pathways is just beginning. Thus, the future will
see combined efforts to develop and transfer new know-
ledge to the herd level. The degree of success in using
genetic resistance as an alternative in controlling PRRS
will be measured in terms of microbiological and health
parameters, but also in terms of availability for pig popula-
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